Schizophrenia
Schizophrenia
01/29/2020
FDA has strengthened an existing warning of constipation associated with the use of clozapine, stating that this constipation can, uncommonly, progress to serious bowel complications, including blockage of...
01/29/2020
c difficile
c difficile
01/28/2020
The FDA has expanded the approval of a drug used for the treatment of C. difficile infection to include pediatric patients aged 6 months and older.
01/28/2020
c difficile
c difficile
01/24/2020
The FDA has expanded the approval of a drug used for the treatment of C. difficile infection to include pediatric patients aged 6 months and older.
01/24/2020
c difficile
c difficile
01/24/2020
The FDA has expanded the approval of a drug used for the treatment of C. difficile infection to include pediatric patients aged 6 months and older.
01/24/2020
c difficile
c difficile
01/24/2020
The FDA has expanded the approval of a drug used for the treatment of C. difficile infection to include pediatric patients aged 6 months and older.
01/24/2020
FDA
FDA
01/21/2020
The US Food and Drug Administration has granted approval to a treatment for thyroid eye disease. It is the first-ever drug to be approved for this indication.
01/21/2020
FDA
FDA
01/21/2020
The US Food and Drug Administration has granted approval to a treatment for thyroid eye disease. It is the first-ever drug to be approved for this indication.
01/21/2020
FDA
FDA
01/21/2020
The US Food and Drug Administration has granted approval to a treatment for thyroid eye disease. It is the first-ever drug to be approved for this indication.
01/21/2020
FDA
FDA
01/07/2020
The US Food and Drug Administration has approved the first and only fast-acting mealtime insulin injection that does not have a pre-dosing recommendation for use in children with diabetes.
01/07/2020
FDA
FDA
01/07/2020
The US Food and Drug Administration has approved the first and only fast-acting mealtime insulin injection that does not have a pre-dosing recommendation for use in children with diabetes.
01/07/2020